Predicting response to chemotherapy using gene expression markers

Details for Australian Patent Application No. 2005304824 (hide)

Owner Genomic Health, Inc. NSABP Foundation, Inc.

Inventors Shak, Steven; Paik, Soonmyung; Bryant, John L.; Baker, Joffre B.

Agent Griffith Hack

Pub. Number AU-B-2005304824

PCT Pub. Number WO2006/052862

Priority 60/625,485 05.11.04 US

Filing date 4 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 22 December 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G06F 19/00 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific applications

Event Publications

17 May 2007 PCT application entered the National Phase

  PCT publication WO2006/052862 Priority application(s): WO2006/052862

22 December 2011 Application Accepted

  Published as AU-B-2005304824

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005304829-System and method for detecting EAS/ RFID tags using step listen

2005304822-Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation